INDIANAPOLIS (AP) -- Johnson & Johnson indicated Wednesday it might cancel its planned $25.4 billion acquisition of struggling medical device maker Guidant Corp. even as federal regulators gave conditional approval for the deal.
http://c.moreover.com/click/here.pl?r416416707
http://c.moreover.com/click/here.pl?r416416707